FDA head says working with India to improve drug quality, safety

Tags: FDA, News
The U.S. Food and Drug Administration is working with Indian regulators to enhance the

RELATED ARTICLES

quality and safety of drugs made there, the FDA's Commissioner Margaret Hamburg said on Tuesday.

Hamburg also urged Indian regulators to work closely with their foreign peers.

Hamburg was speaking to reporters at the end of a visit to India which follows FDA decisions to ban the shipment of drugs to the United States from plants of leading Indian drugmakers including Ranbaxy Laboratories Ltd and Wockhardt Ltd .

During a visit that started on February 10, Hamburg met the Indian drugs regulator and health ministry officials as well as executives of local drugmakers.

Post new comment

E-mail ID will not be published
CAPTCHA
This question is for testing whether you are a human visitor and to prevent automated spam submissions.

EDITORIAL OF THE DAY

  • 49 per cent FDI in defence should pave the way for modernisation

    There is one industrial sector in India that has been kept out of the purview of the normal cycle of investment and production — defence.

FC NEWSLETTER

Stay informed on our latest news!

INTERVIEWS

GV Nageswara Rao

MD & CEO, IDBI Federal Life

Timothy Moe

Goldman Sachs

Chander Mohan Sethi

CMD, Reckitt Benckiser India

COLUMNIST

Tushar Gandhi

Welfare must be humanitarian not political

We are a very political people. We politicise and corrupt ...

Purnendu Ghosh

How to distinguish a need from a want?

The day when the annual budget is announced is one ...

Shona Adhikari

Decades apart, yet a common ground in fine art

Today’s column is about two artists born many decades apart, ...

INTERVIEWS

William D. Green

Chairman & CEO, Accenture